Healthcare -
Biotechnology - NASDAQ - US
$ 36.2
-0.958 %
$ 10.3 B
Market Cap
23.35
P/E
EXEL - DEPRECIATION & AMORTIZATION
Depreciation & Amortization EXEL - Exelixis, Inc.
25.7 M
LAST VALUE
37.36%
2 YEAR CAGR
27.05%
5 YEAR CAGR
23.38%
10 YEAR CAGR